Moreover, visceral adipose tissue, a type of fat targeted by FGF21 that is especially sensitive to metabolic disease‐associated alterations, and liver, could not be studied for the obvious reasons that such biopsies cannot ethically be obtained from aged healthy volunteers. This evidence concerns the gene FGF21 and metabolic disease.